Journal Club - Decision Making at Interims and DMCs (Joint DIA Event)

Joint PSI Pharmaceutical Statistics & DIA Statistics Community 

DIA Chair: Susan Duke, Manager, Benefit Risk Evaluation, GSK 

Speaker: Andreas Sashegyi, Research Advisor, Decision Sciences Lilly Corporate Center, Lilly
A Benefit-risk Model to Facilitate DMC-sponsor Communication and Decision Making
Andreas Sashegyi
Drug Information Journal, Vol. 45, pp. 749-757, 2011
Abstract | Paper+ | Slides

PSI Chair
: Katherine Hutchinson, Head of Consultancy, Quanticate
Speaker: Sara Hughes, VP, Clinical Statistics, GSK
Informing the selection of futility stopping thresholds: case study from a late-phase clinical trial  
Sara Hughes, Robert L. Cuffe, Alfons Lieftucht and W. Garrett Nichols 
Pharmaceutical Statistics, Vol. 8, Issue 1, pp. 25-37, 2009
Abstract | Paper+ | Slides 

: Lisa LaVange, Director, Office of Biostatistics in the Office of Translational Sciences, FDA

+ Papers available to view from 5th June 2012 to 3rd July 2012.

For a flier advertising the event, please click here.

Upcoming Events

Latest Jobs